Treatment of rheumatoid arthritis with biologic DMARDS (Rituximab and Etanercept).

Medicinski arhiv

Volumn 68, Issue 1, 2014, Pages 51-53

  Gashi, Afrim A ^a   Rexhepi, Sylejman ^a   Berisha, Idriz ^a   Kryeziu, Avni ^a   Ismaili, Jehona ^a   Krasniqi, Gezim ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; IMMUNOGLOBULIN G; METHOTREXATE; MONOCLONAL ANTIBODY; RITUXIMAB; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; METHOTREXATE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 84901828208     PISSN: 0350199X     EISSN: None     Source Type: Journal    
DOI: 10.5455/medarh.2014.68.51-53     Document Type: Article

References (0)